Meta-analysis of Usefulness of Drug Coated Balloon versus Standard Balloon in the Treatment of Femoropopliteal In-stent-restenosis

The current guidelines for the treatment of femoropopliteal disease recommend percutaneous transluminal angioplasty [PTA] either alone or in combination with atherectomy, drug-coated balloon angioplasty or angioplasty integrated with stent implantation as feasible alternatives. Although the use of stents has improved the patency rates following PTA in femoropopliteal disease, the rates of in-stent stenosis [ISR] ranges from 15% to 32%. The evidence and guidelines for the management of ISR post femoropopliteal stent implantation are not conclusive.
Source: The American Journal of Cardiology - Category: Cardiology Authors: Source Type: research